Tolmar Therapeutics Inc.
Tolmar Therapeutics Inc., headquartered in the United States, is a prominent player in the biopharmaceutical industry, specialising in the development and commercialisation of innovative therapies. Founded in 2000, the company has made significant strides in addressing unmet medical needs, particularly in the fields of urology and oncology. With a focus on unique drug delivery systems and patient-centric solutions, Tolmar Therapeutics offers a range of core products that stand out for their efficacy and safety profiles. The company has established a strong market position, recognised for its commitment to improving patient outcomes through advanced therapeutic options. Notable achievements include successful partnerships and a robust pipeline that underscores its dedication to innovation in healthcare.
DitchCarbon Score
How does Tolmar Therapeutics Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tolmar Therapeutics Inc.'s score of 23 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tolmar Therapeutics Inc.'s reported carbon emissions
Tolmar Therapeutics Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their carbon footprint in terms of kg CO2e across Scope 1, 2, or 3 emissions. While the company has not outlined any formal climate commitments or initiatives, it is essential to note that many organisations in the pharmaceutical sector are increasingly focusing on sustainability and reducing their environmental impact. This trend often includes setting science-based targets and engaging in various reduction initiatives to align with global climate goals. Without specific data or commitments from Tolmar Therapeutics Inc., it remains unclear how they are addressing climate change and carbon emissions within their operations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tolmar Therapeutics Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
